Stock listing

NASDAQ:IOVA Iovance Biotherapeutics, Inc. Stock

Home listing (NASDAQ) of Iovance Biotherapeutics, Inc.

Follow Iovance Biotherapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:IOVA

$13.62 USD -1.10 (-7.5%)

Close on Oct 16, 2026

Iovance Biotherapeutics, Inc. logo
Ticker
NASDAQ:IOVA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Iovance Biotherapeutics (NASDAQ:IOVA) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 8:30 AM ET

    Watch Transcript

  • Iovance Biotherapeutics (NASDAQ:IOVA) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 8:30 AM ET

    Watch Transcript

  • Iovance Biotherapeutics (NASDAQ:IOVA) Q4 2025 Earnings Call

    Tue, Feb 24, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Oct 16, 2026

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

Oct 1, 2026

Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million

Sep 29, 2026

Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026

Jul 30, 2026

Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

Jun 3, 2026

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

Jun 1, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 22, 2026

May 26, 2026

Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates

May 7, 2026

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

Apr 27, 2026

Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates

Feb 24, 2026

All Iovance Biotherapeutics, Inc. news

Decks

Iovance Biotherapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 105 in all · newest Oct 16, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Aug 6, 2026
Decks
44 decks · latest Oct 5, 2026

Where Iovance Biotherapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:IOVA · Home listing · This pageNASDAQUnited StatesUSD
gettex:2LBgettexGermanyEUR
LS Exchange:A2DT49LS ExchangeGermanyEUR
Tradegate:2LBTradegateGermanyEUR
Frankfurt:2LBFrankfurtGermanyEUR
BOATS:IOVABOATSUnited StatesUSD
Lang & Schwarz:A2DT49Lang & SchwarzGermanyEUR
BX Swiss:IOVABX SwissSwitzerlandCHF
Dusseldorf:2LBDusseldorfGermanyEUR
LSE:0JDKLSEUnited KingdomUSD
Milan:1IOVAMilanItalyEUR
Stuttgart:2LBStuttgartGermanyEUR
Hamburg:2LBHamburgGermanyEUR
Munich:2LBMunichGermanyEUR

Log in to ask 6ix AI your own questions about Iovance Biotherapeutics, Inc.